Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.82 USD | +5.55% | +11.81% | +246.19% |
Business Summary
Number of employees: 50
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Lind
CEO | Chief Executive Officer | 47 | 02/01/20 |
Brandi Roberts
DFI | Director of Finance/CFO | 50 | 31/12/20 |
Chief Tech/Sci/R&D Officer | - | - | |
Dewey McLin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - | |
Randall Kaye
CTO | Chief Tech/Sci/R&D Officer | 62 | 20/03/22 |
Julie Baker
PRN | Corporate Officer/Principal | - | 31/12/22 |
Gus Cardenas
PRN | Corporate Officer/Principal | - | - |
Anne Danks
PRN | Corporate Officer/Principal | - | - |
Marco Peters
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 66 | 30/11/20 |
Director/Board Member | 68 | 30/11/20 | |
Vincent Aurentz
BRD | Director/Board Member | 56 | 31/01/20 |
Casey Lynch
BRD | Director/Board Member | 50 | 31/01/21 |
Kevin Lind
CEO | Chief Executive Officer | 47 | 02/01/20 |
Corinne Le Goff
BRD | Director/Board Member | 58 | 28/02/21 |
Jane Tiller
BRD | Director/Board Member | 59 | 14/11/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2,420,755 | 0 | 0 | 92.26 % |
Stock B | 1 | 33,607,490 | 33,241,120 ( 98.91 %) | 0 |
Company contact information
Longboard Pharmaceuticals, Inc.
4275 Executive Square Suite 950
92037, La Jolla
+
http://www.longboardpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+246.19% | 767M | |
-2.65% | 103B | |
+1.75% | 95.28B | |
+1.46% | 22.15B | |
-15.72% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.47% | 16.05B | |
+5.43% | 13.68B | |
+34.20% | 12.17B |
- Stock Market
- Equities
- LBPH Stock
- Company Longboard Pharmaceuticals, Inc.